Type 2 diabetes surges among young women, often caught too late

A generation ago, type 2 diabetes was a disease of middle age—something that arrived in your fifties or sixties, usually after decades of sedentary living and poor eating habits. Type 1 was the young person's disease, the genetic autoimmune condition that struck without warning. That clear boundary has collapsed. Across England, Germany, and beyond, researchers are now documenting a sharp rise in type 2 diabetes diagnoses among women under 40, with the steepest increases appearing in women in their 20s and 30s.

When Imperial College London researchers analyzed England's National Diabetes Audit data spanning 2011 to 2024, the pattern became unmistakable. While type 2 diabetes prevalence was actually declining among adults aged 60 to 79, it was climbing steadily in younger age groups. The sharpest increases appeared among white, Asian, and Black women in their 20s, and white women in their 30s. Shivani Misra, the lead researcher and a clinical associate professor of diabetes at Imperial College London, noted that much of the public health conversation had focused on ethnic minority populations bearing disproportionate burden. But the new data revealed something broader: this was becoming a generational challenge cutting across racial and ethnic lines. In Germany, the picture mirrors the UK. Baptist Gallwitz, an endocrinologist and spokesperson for the German Diabetes Society, described the situation plainly: type 2 diabetes is rising in many countries, and it functions as a pandemic. Between 2014 and 2023, Germany documented a 5.8 percent annual increase in type 2 diabetes cases among youth aged 11 to 17.

The culprit is not mysterious. Genetic predisposition matters, but lifestyle dominates. Gallwitz articulated the core problem: modern life discourages movement while flooding the diet with sugar and excess calories. The result is rising obesity among young people, which in turn dramatically elevates type 2 diabetes risk. In type 2 diabetes, the body either produces insufficient insulin or the insulin it makes fails to work effectively on cells, leaving glucose to accumulate in the bloodstream. Unlike type 1, where insulin-producing cells are destroyed entirely, type 2 represents a breakdown in the body's ability to regulate blood sugar.

What makes this trend particularly alarming is that the disease behaves differently in young patients. Helen Kirrane from Diabetes UK explained that while any type 2 diabetes diagnosis carries weight, the condition can progress more aggressively in younger people, multiplying the risk of serious complications and shortening lifespans. Early intervention becomes critical. Germany's Diabetes Society has called for systemic change: a tiered tax system making fresh produce affordable while raising prices on foods high in saturated fats and sugar, healthier cafeteria options in schools and kindergartens, and one hour of mandatory daily movement built into school schedules. But Alexandra Kautzky-Willer, head of endocrinology and metabolism at the Medical University of Vienna and a professor of gender medicine, pointed to a dimension often overlooked in these discussions. Creating conditions for movement matters—but those conditions must account for women's safety. A woman who fears harassment, ridicule about her body, or assault in darkness is far less likely to run after work or join a gym. Prevention cannot be divorced from the lived environment.

There is another, more insidious problem: many women with type 2 diabetes are not being diagnosed until the disease has already advanced. Kautzky-Willer and a colleague documented this in a 2025 report for a German medical journal, finding that men typically receive diagnoses at younger ages. By the time women are diagnosed, they are more likely to be obese, to have hypertension, and to have gained more weight than men at their point of diagnosis—all factors that compound the risk of stroke and heart attack. The reason lies partly in how doctors test for diabetes. The standard initial screening measures fasting blood sugar, the glucose level after eight hours without food. It is a single snapshot, missing the blood sugar spikes that occur after eating. Fasting blood sugar is generally lower in women than in men, making the test less sensitive for catching early disease in women. A glucose tolerance test—which involves multiple blood draws over two hours—would be more reliable. So would testing HbA1c levels, which reveal average blood sugar over two to three months by measuring how much glucose has attached to red blood cells. But these more thorough tests require more time and specialized equipment. In Germany and Austria, health insurance covers only the fasting blood sugar test, leaving the more sensitive options out of reach for most patients.

The stakes of this diagnostic gap are substantial. People identified as pre-diabetic—those whose blood values approach but have not yet crossed the diabetes threshold—still have a window to reverse course. Lifestyle and nutrition changes can halt disease progression in some cases, sparing them from years of medication, complications, and reduced life expectancy. But that window closes quickly, and it closes faster when diagnosis comes late. The question facing health systems now is whether they will invest in the more complex, more expensive testing that could catch disease earlier in women, or continue relying on a method that systematically misses it.